کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1230036 1495198 2017 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
High wavenumber Raman spectroscopy in the characterization of urinary metabolites of normal subjects, oral premalignant and malignant patients
ترجمه فارسی عنوان
طیف سنجی رامان عدد موج بالا در خصوصیات متابولیت ادراری افراد سالم، سرطانی دهان و بیماران بدخیم
کلمات کلیدی
طیف سنجی رعد و برق بالا؛ ادرار زودرس زودرس Flavins؛ تریپتوفان؛ فنیل آلانین؛ PC-LDA
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی آنالیزی یا شیمی تجزیه
چکیده انگلیسی


• Urine is considered as an important biofluid in diagnostic oncology as it has many metabolites
• Raman spectroscopic characterization of normal and diseased urine were made in finding the suitable biomarkers
• Flavoproteins, Tryptophan and Phenylalanine contributes more for the observed spectral variations

Urine has emerged as one of the diagnostically potential bio fluids, as it has many metabolites. As the concentration and the physiochemical properties of the urinary metabolites may vary under pathological transformation, Raman spectroscopic characterization of urine has been exploited as a significant tool in identifying several diseased conditions, including cancers. In the present study, an attempt was made to study the high wavenumber (HWVN) Raman spectroscopic characterization of urine samples of normal subjects, oral premalignant and malignant patients. It is concluded that the urinary metabolites flavoproteins, tryptophan and phenylalanine are responsible for the observed spectral variations between the normal and abnormal groups. Principal component analysis-based linear discriminant analysis was carried out to verify the diagnostic potentiality of the present technique. The discriminant analysis performed across normal and oral premalignant subjects classifies 95.6% of the original and 94.9% of the cross-validated grouped cases correctly. In the second analysis performed across normal and oral malignant groups, the accuracy of the original and cross-validated grouped cases was 96.4% and 92.1% respectively. Similarly, the third analysis performed across three groups, normal, oral premalignant and malignant groups, classifies 93.3% and 91.2% of the original and cross-validated grouped cases correctly.

Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy - Volume 171, 15 January 2017, Pages 52–59
نویسندگان
, , , , ,